Sanofi appoints Audrey Duval Derveloy as global head of corporate affairs

21 June 2024
sanofi_large

Audrey Duval Derveloy, currently president of Sanofi France, has been named executive vice president, global head of corporate affairs.

Ms Duval Derveloy will also become a member of French pharma major Sanofi’s (Euronext: SAN) executive committee, reporting into chief executive Paul Hudson, and will be based in Paris. Her appointment is effective July 1, 2024.

In her new role, Ms Duval Derveloy will be responsible for Sanofi’s stakeholder engagement globally, and oversee the company’s corporate social responsibility strategy, not-for-profit Global Health Unit and Sanofi’s philanthropic arm, Foundation S. She retains her role as president, Sanofi France, and will continue supporting and coordinating Sanofi’s representation to its various external stakeholders in this country.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical